Hasil Pencarian
	Ditemukan 622 dokumen dengan kata kunci 7598 Simpan CSV  Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer No. Panggil: Annals of Oncology; Volume 24, No.8, August, 2013,p.2005-20011 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2- positive metastatic breast cancer pretreated with anti- HER2 therapy No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p.109-116 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1841-1847 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA No. Panggil: Annals of Oncology; Volume 24, No.9, September, 2013, p.2278-2284 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human am integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer No. Panggil: Annals of Oncology; Volume 24, No.2, February,2013,p.329-336 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1769-1777 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Attitudes of patients with metastatic breast cancer toward research biopsies No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1853-1859 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer?† No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1834-1840 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer No. Panggil: Annals of Oncology; Volume 24, No.8, August, 2013,p.1999-2004 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1526-1533 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Prev   1 2 3 4 5 6 7 8 9 10  Next